Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

759

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Opioid Dependence, on Agonist Therapy
Interventions
DRUG

BNX sublingual tablets

Buprenorphine/naloxone sublingual tablets

DRUG

BNX sublingual film

Buprenorphine/naloxone sublingual film

DRUG

Buprenorphine

Buprenorphine sublingual tablets

Trial Locations (36)

Unknown

Baldwin County

Houston County

Maricopa

Beverly Hills

Los Angeles County

Riverside County

San Diego County

Broward County

Colombia County

Duval County

Greater Metro Orlando

Lake County

Miami-Dade County

Osceola County

Palm Beach County

DeKalb County

Chicagoland

Johnson County

Kenton County

Caddo Parish

Baltimore County

Bristol County

Saint Louis Metro Area

Camden County

Warren County

Warren County

Oklahoma County

Portland Metropolitan Area

Allegheny County

Delaware County

Philadelphia County

Charleston County

Dallas County

Salt Lake County

Charlottesville Metropolitan Area

Benton County

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Worldwide Clinical Trials

OTHER

lead

Orexo AB

INDUSTRY